ICCC News and Press, ImmuCell Corporation From 08/10/23

2023-08-10 16:29:50 ET ImmuCell press release ( NASDAQ: ICCC ): Q2 GAAP EPS of -$0.18. Revenue of $3.53M (-8.5% Y/Y). For further details see: ImmuCell GAAP EPS of -$0.18, revenue of $3.53M

PORTLAND, Maine, Aug. 10, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health a...

PORTLAND, Maine, Aug. 07, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health a...

2023-07-11 18:02:37 ET ImmuCell ( NASDAQ: ICCC ) on Tuesday announced preliminary Q2 sales that fell from a year ago. The company reported sales of $3.53M in Q2 2023, a 9% decrease from $3.86M in the same period last year. ICCC cited the lower sales to its previously discl...

PORTLAND, Maine, July 11, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health a...

2023-06-28 18:14:23 ET ImmuCell ( NASDAQ: ICCC ) said it is delaying resubmission of its market application to the US Food and Drug Administration for its dairy cattle medication Re-Tain by one month in order to better prepare for a re-inspection of its manufacturing facilities. ...

PORTLAND, Maine, June 28, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health a...

PORTLAND, Maine, June 21, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health a...

2023-06-15 17:50:43 ET Dairy and beef cattle health company ImmuCell ( NASDAQ: ICCC ) said Thursday it expects to resolve its contamination problem and anticipates resuming full production for the second half of 2023 and beyond. The company said its goal was to produce about $...

PORTLAND, Maine, June 15, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health a...